MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
Go back to MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.93 +0.09 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.84 | 52 Week High | $2.51 | |||
| Open | $3.85 | 52 Week Low | $0.41 | |||
| Day High | $3.95 | P/E | N/A | |||
| Day Low | $3.77 | EPS | $-0.64 | |||
| Volume | 3,234,320 | |||||
| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.93 +0.09 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.84 | 52 Week High | $2.51 | |||
| Open | $3.85 | 52 Week Low | $0.41 | |||
| Day High | $3.95 | P/E | N/A | |||
| Day Low | $3.77 | EPS | $-0.64 | |||
| Volume | 3,234,320 | |||||

